Earnings Scheduled For March 27, 2024
Companies Reporting Before The Bell
• Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million.
Earnings Preview For Cellectar Biosciences
Cellectar Biosciences (NASDAQ:CLRB) is set to give its latest quarterly earnings report on Wednesday, 2024-03-27. Here’s what investors…
Why Is Cancer-Focused Cellectar Biosciences Stock Trading Higher Today?
Cellectar Biosciences Inc (NASDAQ: CLRB) announced data from its CLOVER WaM pivotal study, evaluating iopofosine I 131, a targeted radiotherapy candidate for the treatment of relapsed/refractory Waldenstrom's macroglobulinemia (WM) patients that have received at
Cellectar Biosciences Expands A New Licensing Agreement With The Wisconsin Alumni Research Foundation For Intellectual Property That Was The Result Of Collaborative Research With Iopofosine I 131 In Pediatric Cancers
Cellectar Biosciences, Inc. (NASDAQ:CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced a new licensing
Cellectar Biosciences Strengthens Intellectual Property Protection For Its PDC Platform
Cellectar Biosciences, Inc. (NASDAQ:CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that is has
Earnings Scheduled For November 2, 2023
Companies Reporting Before The Bell
• AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.
Cellectar Biosciences Expands Commercialization Leadership Team Ahead Of Pivotal Data for Iopofosine I-131 in Waldenstrom’s Macroglobulinemia
William Yoon Appointed Vice President, Medical Affairs
Aaditya Nanduri Appointed Vice President, Business Strategy and Analytics
FLORHAM PARK, N.J., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc.
12 Health Care Stocks Moving In Friday’s Intraday Session
Gainers Myomo (AMEX:MYO) stock moved upwards by 20.1% to $1.25 during Friday’s regular session. Trading volume for Myomo’s…
Cellectar Biosciences Receives European Medicines Agency Priority Medicines Designation For Iopofosine For Waldenstrom’s Macroglobulinemia
Cellectar Biosciences, Inc. (NASDAQ:CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of targeted drugs for the treatment of cancer, today announced that
12 Health Care Stocks Moving In Wednesday’s Pre-Market Session
Gainers Palisade Bio (NASDAQ:PALI) stock increased by 65.3% to $1.14 during Wednesday’s pre-market session. The market value of…